PACTT is celebrating its 25th anniversary on May 14—let’s celebrate together!

Join us in celebrating 25 years of innovation and research translation at UNIL and CHUV. When? May 14, 2025, starting at 2:00 p.m. (registration required). Where? Biopôle, Auditorium in Building SE-C. In 2000, the Canton of Vaud decided to establish a unit at UNIL and CHUV dedicated to the “commercialization of research results.” Since then, […]

Join us in celebrating 25 years of innovation and research translation at UNIL and CHUV.

When? May 14, 2025, starting at 2:00 p.m. (registration required).

Where? Biopôle, Auditorium in Building SE-C.

In 2000, the Canton of Vaud decided to establish a unit at UNIL and CHUV dedicated to the “commercialization of research results.” Since then, PACTT has supported researchers in translating their inventions into benefits for society and patients, as well as in developing collaborations with partners to transform their results and innovations into products and services.

Twenty-five years later, this commercialization work has evolved in response to societal needs and technological advances. In addition to traditional patents, the importance of clinical data, software, and unique know-how has grown, presenting both challenges and opportunities.

Supported by the CHUV’s Department of Innovation and Clinical Research and the UNIL’s Vice-Rectorate for Research, this event will bring together key stakeholders from the public and private sectors, researchers, innovative companies, and decision-makers.

Together, we will explore future prospects for research collaborations, the commercialization of scientific findings, life sciences startups, and innovation.

PROGRAM

ROUNDTABLE 1: CLINICAL DATA UTILIZATION: HOW CAN WE PROTECT PATIENTS AND STIMULATE INNOVATION?

  • Astrid Kiermaier, Leader for Personalized Healthcare, Roche
  • Juan Ramón Troncoso-Pastoriza – CEO, TuneInsight.
  • Philippe Gilliéron – Attorney at BMG LAW, Associate Professor at UNIL
  • Jonas Richiardi – Director of the Translational Machine Learning Lab, CHUV.
  • Alexander Schaub – Co-Lead of Translational Research, CSL Behring.
  • Patrick Hirschi, Project Lead for the Swiss Health Data Space, DigiSanté, FOPH.

Moderator: Raphael Gottardo – Biomedical Data Science Center, CHUV.

*** NETWORKING BREAK ***

ROUNDTABLE 2: ENTREPRENEURSHIP, LICENSING, AND ALTERNATIVE APPROACHES TO RESEARCH COMMERCIALIZATION

  • Rik Buschman – Distinguished Scientist in Clinical Research, Medtronic.
  • Lolita Bazarova – Portfolio & Innovation Lead, Nestlé Research.
  • Jan-Willem Veening – Director, Department of Fundamental Microbiology, UNIL.
  • Christophe Champod – Director, School of Criminal Sciences, UNIL.
  • Jocelyne Bloch – Director, Neurosurgery, CHUV & Director of NeuroRestore.

Moderator: Tom Hockaday – Former Director of the Oxford University Technology Transfer Office (TTO).

PITCH COMPETITION & AWARDS CEREMONY

  • Project pitches
  • 2025 Commercialization Award

*** NETWORKING COCKTAIL RECEPTION ***

Program

Registration

Table of Contents

Interested in this project? Let’s Talk

Get in touch to discuss licensing opportunities, collaborative research, or technical specifications.

Other news & events

Uncategorized
InnoTREK: one-year financial support to create your start-up

You are a UNIL CHUV researcher who would like to create a start-up and need...

Uncategorized
BioInnovation Day 2026: A Day Dedicated to Innovators & Investors

The BIND BioInnovation Day 2026 will take place on April 1, 2026, at the CHUV...

Uncategorized
A Unil Discovery for Vaccine Development Turns into a Start-Up

The CRISPRi-seq technology, stemming from fundamental research within the team of Professor Jan-Willem Veening at...

What is your situation ?

Our team is available to discuss your needs, for free.

For Researcher

A personalized service to inventors
In collaboration with a professional network, with regards to all aspects of technology evaluation, protection of intellectual property rights and creation of a start-up.

For Industry

Find a collaboration, or invest in a technology
We are the primary contact point to engage in any collaboration, partnership or venture with researchers from the University of Lausanne or the CHUV.